Central Europe Malaria Newswire

Get by Email • RSS

Published on Dec 8, 2023

WHO 'very worried' about spread of mpox in DRC

The World Health Organisation (WHO) logo is seen near its headquarters in Geneva, Switzerland, February 2, 2023. REUTERS/Denis Balibouse Acquire Licensing Rights LONDON, Dec 8 (Reuters) - The World Health Organization is “very worried” about the spread …

Source: Reuters - Neutral
Published on Dec 7, 2023

New $1 billion plan for African vaccine manufacturing -GAVI Alliance

Researchers studying the BCG vaccine for tuberculosis test samples in a laboratory run by South African biotech company TASK in Cape Town, South Africa, May 11, 2020. Picture taken May 11, 2020. REUTERS/Mike Hutchings//File Photo Acquire …

Source: Reuters - Neutral
Published on Dec 7, 2023

WHO says more contaminated medicinal syrups found in new regions

The World Health Organisation (WHO) logo is seen near its headquarters in Geneva, Switzerland, February 2, 2023. REUTERS/Denis Balibouse/File Photo Acquire Licensing Rights Dec 7 (Reuters) - The World Health Organization on Thursday said several …

Source: Reuters - Neutral
Published on Dec 7, 2023

20 Countries with Free Health Care

In this article, we will be taking a look at the 20 countries with free health care. To skip our detailed analysis, you can go directly to see the 5 countries with free health care. The U.S. is one of the only advanced countries in the world to not have …

Source: Insider Monkey - Neutral
Published on Dec 7, 2023

Poverty mustn’t become the comparative advantage of Africa – Adesina

Dr Akinwumi A. Adesina When he Dr Akinwumi A. Adesina, President of the African Development Bank Group, gave the keynote at the 40th anniversary of The Guardian Newspapers in Lagos, Nigeria, 28 November 2023, he advised that poverty must not become the …

Source: The News (Nigeria) - Uncategorized
Published on Dec 7, 2023

On the ground in Moldova: how the country fights tuberculosis

If Olga had waited just a little longer before seeking help, she would probably not be alive. Battling tuberculosis (TB) was a traumatising experience, she recalls, something she does not wish on anyone. The 41-year-old is standing in the living room of …

Source: The Parliament Magazine - Neutral

22 days 08:17:48

Get free press releases
& use them anytime during 12 months

Featured Releases

Got News to Share? · Submit · See All

Published on December 5, 2023 - 13:15 GMT

Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression ...

Results published in the Journal Immunity share discovery of a new mechanism by which Chi3L1 regulates breast cancer development and progression PROVIDENCE, Rhode Island, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 1, 2023 - 17:55 GMT

Alicorp A : We form an alliance against the El Niño Phenomenon

The arrival of the El Niño Phenomenon is a fact for which we must be prepared, since heavy rains can generate floods and deteriorate infrastructure. That is why Alicorp, in alliance with Juguete Pdiente and Acción contra el Hambre, signed an agreement to …

Distribution channels: International Organizations

Got news to share? Submit it now.

Load more malaria news or search news using your own keywords. There are 674,219,298 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Malaria News by Country

Malaria News by U.S. State

Malaria News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 11/25/2023

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on December 11, 2023 - 01:13 GMT

Embolotherapy Market: Technologies, Innovations, Dynamics, Growth Prospects and Industry Forecast, 2023-2032

Embolotherapy Market Analysis Report by End user, by Procedure and by Disease indication: Global Opportunity Analysis and Industry Forecast, 2023-2032 NEW CASTLE, DELAWARE, UNITED STATES, December 11, 2023 /⁨EINPresswire.com⁩/ -- Embolotherapy, a …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on December 10, 2023 - 20:02 GMT

Baltimore Musical Seeks To Turn The Tide of Addiction & Overdose-Related Deaths

Theatrical Dramedy Takes a Riveting Look at The Opioid Epidemic; Cast Includes Former Drug Dealer Turned National Recording Artist BALTIMORE, MARYLAND, USA, December 10, 2023 /⁨EINPresswire.com⁩/ -- Baltimore has the highest number of drug …

Distribution channels: Amusement, Gaming & Casino, Culture, Society & Lifestyle ...
Published on December 10, 2023 - 15:33 GMT

U.S. Protein Supplement Market Size Growing at 7.7% CAGR to Hit $3.58 billion by 2028

U.S. Protein Supplement Market was pegged at $1.92 billion in 2019, and is expected to reach $3.58 billion by 2028, growing at a CAGR of 7.7% from 2021 to 2028. PORTLAND, OREGON, UNITED STATES, December 10, 2023 /⁨EINPresswire.com⁩/ -- Rise in …

Distribution channels: Healthcare & Pharmaceuticals Industry, Sports, Fitness & Recreation ...
Published on December 10, 2023 - 14:00 GMT

Genesis Counseling Clinches a 2023 Best of Florida Awards: A Testament to Transformative Healing and Community Impact

BOCA RATON, FLORIDA, UNITED STATES, December 10, 2023 /⁨EINPresswire.com⁩/ -- Genesis Counseling is a haven for those who seek excellence in mental health care for individuals of all ages, from children and teenagers to adults. The core values of …

Distribution channels: Business & Economy, Consumer Goods ...
Published on December 11, 2023 - 00:30 GMT

Press Release: Sarclisa® (isatuximab) plus KRd significantly improved rate of minimal residual disease negativity in ...

Sarclisa® (isatuximab) plus KRd significantly improved rate of minimal residual disease negativity in transplant-eligible patients with newly diagnosed multiple myeloma versus KRd alone Phase 3 data showed Sarclisa added to carfilzomib, lenalidomide and …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on December 11, 2023 - 00:30 GMT

CP : Sarclisa® (isatuximab) plus KRd améliore significativement le taux de maladie résiduelle minimale négative des ...

Sarclisa® (isatuximab) plus KRd améliore significativement le taux de maladie résiduelle minimale négative des patients atteints d’un myélome multiple nouvellement diagnostiqué, éligibles à une greffe, comparativement à l’association KRd seule Les données …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on December 11, 2023 - 00:30 GMT

Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of ...

APPLY-PNH extension data show that continuous Fabhalta® (iptacopan) treatment in adults with paroxysmal nocturnal hemoglobinuria (PNH) enabled sustained hemoglobin-level increases to near-normal (≥12 g/dL), blood transfusion avoidance, and improved …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on December 11, 2023 - 00:30 GMT

Latest Odronextamab Data in Relapsed/Refractory Follicular Lymphoma Showed Compelling Responses and Overall Maintenance ...

Updated results presented at ASH demonstrated an 80% objective response rate and a 73% complete response (CR), with a 23-month median duration of response and 24-month median duration of CR Oral presentation showcased overall maintenance of patient- …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 10, 2023 - 17:30 GMT

Updated Odronextamab Data from Relapsed/Refractory Diffuse Large B-cell Lymphoma Pivotal Trial Showed Deep and Durable ...

Phase 2 primary analysis results presented in ASH oral session demonstrated a 52% objective response rate (ORR), with 31% achieving a complete response (CR) Results from a Phase 1 expansion cohort showed a 48% ORR and 30% CR in patients who had progressed …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 10, 2023 - 17:05 GMT

Centessa Pharmaceuticals Announces New Data from an Additional 52-Weeks of Continuous Treatment from Third Year (Part 5) ...

Part 5 data reinforces favorable safety and tolerability profile and long-term efficacy results for SerpinPC: Median all-bleed ABR of 1.0, a 96% reduction from prospective baseline No thromboembolic events or treatment-related sustained elevations of D- …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 10, 2023 - 17:00 GMT

Molecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533 ...

Initial antitumor activity observed in early MP0533 dose-escalation cohorts, with a previously undisclosed complete response (CR) observed in dose range four, in addition to the previously reported responder in dose range three MP0533 monotherapy continues …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 10, 2023 - 16:00 GMT

Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS ...

REDWOOD CITY, Calif., Dec. 10, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on the development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on December 10, 2023 - 03:57 GMT

Senior Housing Industry Looking to Cut Losses by Bringing In Commercial Cleaning Robots to Automate Fllor Cleaning

The senior housing industry faces increasing pressure to reduce costs while maintaining standards of care. One savior comes in the form of robot floor cleaners LOS ANGELES, CALIFORNIA, UNITED STATES, December 9, 2023 /⁨EINPresswire.com⁩/ -- The …

Distribution channels: Amusement, Gaming & Casino, Building & Construction Industry ...
Published on December 10, 2023 - 03:13 GMT

3Dhearing.com Announces Waldorf, MD Store Offering Premium Hearing Aids at Competitive Prices

3Dhearing.com features discounted premium hearing aids, founded by Kirk Payne with Beltone at 11811 Park Waldorf Ln, Unit 515, MD. WALDORF, MARYLAND, USA, December 9, 2023 /⁨EINPresswire.com⁩/ -- 3Dhearing.com, recognized for its premium hearing …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...
Published on December 9, 2023 - 19:19 GMT

Massage Now Kennesaw Voted "Best of Georgia 2023" for the Third Consecutive Year

Continuing Excellence: Massage Now Reinforces Its Reputation as Georgia's Premier Massage Therapy Destination KENNESAW, GEORGIA, UNITED STATES, December 9, 2023 /⁨EINPresswire.com⁩/ -- Massage Now, a leader in wellness and therapeutic massage, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 9, 2023 - 18:08 GMT

Non-woven Adhesives Market Top Growth Companies, Opportunities Analysis and Industry Forecast

Non-woven Adhesives Market Trends and Innovation PORTLAND, OREGON, UNITED STATES, December 9, 2023 /⁨EINPresswire.com⁩/ -- Allied Market Research's latest report on the global non-woven adhesives market projects a promising outlook, …

Distribution channels: Automotive Industry, Healthcare & Pharmaceuticals Industry ...
Published on December 9, 2023 - 15:14 GMT

Sapura Weed Dispensary Coldwater: Elevating the Cannabis Experience in Michigan

Explore the world of cannabis at Sapura's prominent location in Coldwater, featuring a thoughtfully curated range of high-quality products. COLDWATER, MICHIGAN, UNITED STATES, December 9, 2023 /⁨EINPresswire.com⁩/ -- The cannabis industry in …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...
Published on December 10, 2023 - 00:00 GMT

Agios Presents Positive Results from Phase 2 Portion of the RISE UP Pivotal Study in Sickle Cell Disease at 65th ASH ...

– Treatment with Mitapivat Demonstrated Statistically Significant Improvement in Hemoglobin Response Compared to Placebo – – Improvements Observed in Annualized Rates of Sickle Cell Pain Crises, Markers of Hemolysis and Erythropoiesis in Participants …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 9, 2023 - 22:30 GMT

Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts

At Week 26, 22 weeks after the last dose of BMF-219, the 200 mg cohorts increased the percentage of patients to approximately 40% with durable HbA1c reduction of 1% or more as compared to the 100 mg cohorts which reported earlier as 20%. To date, the dose …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
Published on December 9, 2023 - 18:30 GMT

Cogent Biosciences Announces Positive Initial Data from Phase 2 SUMMIT Trial Evaluating Bezuclastinib in Patients with ...

Rapid and ongoing improvement in patient symptoms, with 57% median best improvement on MC-QoL and 78% of patients reporting ≥1 point improvement on PGIS by week 20 100% of bezuclastinib treated patients achieved at least 50% improvement across all relevant …

Distribution channels: Healthcare & Pharmaceuticals Industry ...